| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CUTTING EDGE |
* Department of Surgery and
Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA 15213; and
Laboratory of Biomedical Science, North Shore University Hospital, New York University School of Medicine, Manhasset, NY 11030
High mobility group box 1 (HMGB1) is a NF released extracellularly as a late mediator of lethality in sepsis and as an early mediator of inflammation following injury. Here we demonstrate that in contrast to the proinflammatory role of HMGB1, preconditioning with HMGB1 results in protection following hepatic ischemia/reperfusion (I/R). Pretreatment of mice with HMGB1 significantly decreased liver damage after I/R. The protection observed in mice pretreated with HMGB1 was associated with a higher expression of IL-1R-associated kinase-M, a negative regulator of TLR4 signaling, compared with controls. We thus explored the possibility that HMGB1 preconditioning was mediated through TLR4 activation. HMGB1 preconditioning failed to provide protection in TLR4 mutant (C3H/HeJ) mice, but successfully reduced damage in TLR4 wild-type (C3H/HeOuj) mice. Our studies demonstrate that in contrast to the role of HMGB1 as an early mediator of inflammation and organ damage in hepatic I/R, HMGB1 preconditioning can be protective.
This article has been cited by other articles:
|
|
 |
|
  R. Lotfi, G. I. Herzog, R. A. DeMarco, D. Beer-Stolz, J. J. Lee, A. Rubartelli, H. Schrezenmeier, and M. T. Lotze Eosinophils Oxidize Damage-Associated Molecular Pattern Molecules Derived from Stressed Cells J. Immunol., October 15, 2009; 183(8): 5023 - 5031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Aneja, A. Tsung, H. Sjodin, J. V. Gefter, R. L. Delude, T. R. Billiar, and M. P. Fink Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance J. Leukoc. Biol., November 1, 2008; 84(5): 1326 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Han, J. Zhong, W. Wei, Y. Wang, Y. Huang, P. Yang, S. Purohit, Z. Dong, M.-H. Wang, J.-X. She, et al. Extracellular High-Mobility Group Box 1 Acts as an Innate Immune Mediator to Enhance Autoimmune Progression and Diabetes Onset in NOD Mice Diabetes, August 1, 2008; 57(8): 2118 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Klune, T. R. Billiar, and A. Tsung HMGB1 preconditioning: therapeutic application for a danger signal? J. Leukoc. Biol., March 1, 2008; 83(3): 558 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Oke and K. J. Tracey From CNI-1493 to the immunological homunculus: physiology of the inflammatory reflex J. Leukoc. Biol., March 1, 2008; 83(3): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Ellerman, C. K. Brown, M. de Vera, H. J. Zeh, T. Billiar, A. Rubartelli, and M. T. Lotze Masquerader: High Mobility Group Box-1 and Cancer Clin. Cancer Res., May 15, 2007; 13(10): 2836 - 2848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rouhiainen, S. Tumova, L. Valmu, N. Kalkkinen, and H. Rauvala Analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin) J. Leukoc. Biol., January 1, 2007; 81(1): 49 - 58. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
